A Study of CS060380 Tablets in Patients With MASH and Obesity

Clinical trial NCT07466017 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07466017
Sponsor: Cascade Pharmaceuticals, Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic Dysfunction-associated Steatohepatitis (MASH)Obesity

Start date: 2026-04-02
Primary completion: 2027-04-30
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.